Application 215357
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | TROCHE/LOZENGE;ORAL | EQ 2MG BASE | No | No |
| 002 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | TROCHE/LOZENGE;ORAL | EQ 4MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215357-001 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | ||
| A215357-002 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-02-18 07:12 UTC | 2024-02 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215357-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215357-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2022-05-13 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NICOTINE | NICOTINE POLACRILEX MINI | Atlantic Biologicals Corp | 5d579f42-4396-1913-e063-6294a90aff7f | 2026-10-05 | Warnings | 215357 ANDA215357 |
| NICOTINE | NICOTINE POLACRILEX MINI | Aurohealth LLC | 5102e242-4d27-4b1f-8a65-2b52ba3f2276 | 2025-05-14 | Warnings | 215357 ANDA215357 58602-854 |
| AMAZON BASIC CARE NICOTINE POLACRILEX | NICOTINE POLACRILEX MINI | Amazon.com Services LLC | 113e54e3-e9c3-4949-e063-6394a90a6fdf | 2025-05-02 | Warnings | 215357 ANDA215357 |
| AMAZON BASIC CARE NICOTINE POLACRILEX | NICOTINE POLACRILEX MINI | Amazon.com Services LLC | 10ee6816-8155-d590-e063-6394a90a9dea | 2025-05-02 | Warnings | 215357 ANDA215357 |
| NICOTINE | NICOTINE POLACRILEX MINI | Aurohealth LLC | 169c7976-f865-4716-953d-383e435d67c5 | 2024-06-20 | Warnings | 215357 ANDA215357 58602-855 |
| NICOTINE | NICOTINE POLACRILEX MINI | BLIP PRODUCTS, INC. | e88c8815-4d38-3a59-e053-2995a90afc82 | 2023-08-11 | Warnings | 215357 ANDA215357 82966-001 |
| NICOTINE | NICOTINE POLACRILEX MINI | BLIP PRODUCTS, INC. | eb714022-332d-5c6f-e053-2a95a90a75c9 | 2023-08-11 | Warnings | 215357 ANDA215357 82966-002 |
| NICOTINE | NICOTINE POLACRILEX MINI | Aurohealth LLC | 85f05cc6-ae2e-4338-8c1e-c681c2f90858 | 2022-11-03 | Warnings | 215357 ANDA215357 58602-723 |
| NICOTINE | NICOTINE POLACRILEX MINI | Aurohealth LLC | cfe6fb63-2897-4e76-8288-1389f363b3c4 | 2022-11-03 | Warnings | 215357 ANDA215357 58602-722 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58602-722 | NICOTINE | NICOTINE POLACRILEX MINI | Aurohealth LLC | ANDA | Current |
| 58602-723 | NICOTINE | NICOTINE POLACRILEX MINI | Aurohealth LLC | ANDA | Current |
| 58602-854 | NICOTINE | NICOTINE POLACRILEX MINI | Aurohealth LLC | ANDA | Current |
| 58602-855 | NICOTINE | NICOTINE POLACRILEX MINI | Aurohealth LLC | ANDA | Current |
| 82966-001 | NICOTINE | NICOTINE POLACRILEX MINI | BLIP PRODUCTS, INC. | ANDA | Current |
| 82966-002 | NICOTINE | NICOTINE POLACRILEX MINI | BLIP PRODUCTS, INC. | ANDA | Current |